PCI Biotech Holding ASA (OSL:PCIB)
Norway flag Norway · Delayed Price · Currency is NOK
1.330
-0.068 (-4.86%)
Apr 2, 2025, 1:19 PM CET

PCI Biotech Holding ASA Cash Flow Statement

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-16.42-20.32-55.1-88.39-72.24
Upgrade
Depreciation & Amortization
0.30.370.632.542.21
Upgrade
Asset Writedown & Restructuring Costs
--5.77--
Upgrade
Stock-Based Compensation
0.831.96-1.2912.946.34
Upgrade
Other Operating Activities
0.060.05-0.122.57-8.45
Upgrade
Change in Accounts Receivable
-3.596.040.961.48
Upgrade
Change in Accounts Payable
-0.22-3.25-1.45-3.41
Upgrade
Change in Other Net Operating Assets
1.47-0.84-11.732.52-3.32
Upgrade
Operating Cash Flow
-13.76-14.97-59.04-68.31-77.39
Upgrade
Capital Expenditures
----0.34-3.92
Upgrade
Investing Cash Flow
----0.34-3.92
Upgrade
Long-Term Debt Repaid
-0.36-0.44-0.68-0.67-0.67
Upgrade
Net Debt Issued (Repaid)
-0.36-0.44-0.68-0.67-0.67
Upgrade
Issuance of Common Stock
----0.32
Upgrade
Financing Cash Flow
-0.36-0.44-0.68-0.67-0.35
Upgrade
Foreign Exchange Rate Adjustments
--0.2-2.538.53
Upgrade
Miscellaneous Cash Flow Adjustments
---0-
Upgrade
Net Cash Flow
-14.12-15.41-59.52-71.85-73.14
Upgrade
Free Cash Flow
-13.76-14.97-59.04-68.65-81.31
Upgrade
Free Cash Flow Margin
-204.28%-500.67%-1242.99%-1094.34%-1103.56%
Upgrade
Free Cash Flow Per Share
-0.37-0.40-1.58-1.84-2.18
Upgrade
Cash Interest Paid
-00.050.2-
Upgrade
Levered Free Cash Flow
-8.65-8.74-44.95-36.62-50.26
Upgrade
Unlevered Free Cash Flow
-8.59-8.64-44.87-36.56-50.01
Upgrade
Change in Net Working Capital
-1.5-2.948.93-2.073.31
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.